MK-8719

N/A

Report date: 2025/05/23 15:36:51
NME

Base Information

Drug NameMK-8719
Drug Alias NameMK-8719
ClassificationDiagnostic agent (In vivo)Small molecules > Heterocyclic drugs
Mechanisms of ActionProtein O-GlcNAcase inhibitors
TargetsProtein O-GlcNAcase
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAlectos Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAlectos Therapeutics
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A